Metraipolis › archive › dc_bb420010ea65

Should Sickle Cell Disease Be Considered a Cancer Predisposition Syndrome? — Europe PMC PMID:42194209

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42194209
DOI: 10.3390/children13050683
License (as archived): solo-consultazione
Archived: 2026-11-01T16:16:15.314Z
SHA-256 of the archived text: d051ccb11f25c69a7401eeb686e2403af29ec7930d3c52218204428c37b77867
Stable URL of this page: https://metraipolis.com/documento/dc_bb420010ea65

How to cite

Should Sickle Cell Disease Be Considered a Cancer Predisposition Syndrome? — Europe PMC PMID:42194209 — Europe PMC (en), https://europepmc.org/article/MED/42194209 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb420010ea65 (Metraipolis archive dc_bb420010ea65, sha256 d051ccb11f25c69a7401eeb686e2403af29ec7930d3c52218204428c37b77867)

BibTeX

@misc{dcbb420010ea65,
  title = {Should Sickle Cell Disease Be Considered a Cancer Predisposition Syndrome? — Europe PMC PMID:42194209},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42194209},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb420010ea65; sha256 d051ccb11f25c69a7401eeb686e2403af29ec7930d3c52218204428c37b77867},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42194209. Agents can read the archived copy with the MCP tool read_document.